Invesco India Pharma and Healthcare Fund vs Nippon India Power & Infra Fund
Direct Plan, Growth option · Data as on 30-10-2026
Invesco India Pharma and Healthcare Fund is a Sectoral fund and Nippon India Power & Infra Fund is a Sectoral fund. Invesco India Pharma and Healthcare Fund charges 3.30% a year and Nippon India Power & Infra Fund 1.11% (Direct plans). Their portfolios overlap 1.4%: they hold 2 of the same securities.
Invesco India Pharma and Healthcare Fund
Sectoral
- Expense ratio
- 3.30%
- NAV
- ₹9.66
Nippon India Power & Infra Fund
Sectoral
- Expense ratio
- 1.11%
- NAV
- ₹381.72
Which is better, Invesco India Pharma and Healthcare or Nippon India Power & Infra? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- Nippon India Power & Infra costs less: 1.11% a year against 3.30% (Direct plans).
- Nippon India Power & Infra fell less in its worst fall since 10-09-2026: −10.4% against −11.4%.
- Nippon India Power & Infra holds more in large companies: 47.1% of the fund in large caps against 29.8%.
- Nippon India Power & Infra is the larger fund: ₹7,867 Cr against ₹436 Cr.
- Their portfolios overlap 1.4%: 2 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | Invesco India Pharma and Healthcare Fund | Nippon India Power & Infra Fund |
|---|---|---|
| Fund house | Invesco Mutual Fund | Nippon India Mutual Fund |
| Category | Sectoral | Sectoral |
| AUM | ₹436 Cr (30-09-2026) | ₹7,867 Cr (30-09-2026) |
| NAV | ₹9.66 (Direct) | ₹381.72 (Direct) |
| Expense ratio (Direct) | 3.30% | 1.11% |
| Expense ratio (Regular) | 5.19% | 1.96% |
| Riskometer | Very High | Very High |
| Benchmark | BSE Healthcare TRI | Nifty Infrastructure TRI |
| Launch date | 01-09-2026 | 08-05-2004 |
| Minimum investment | Not available | ₹5,000 |
| Lock in | None | None |
| Fund managers | Aditya Khemani | Rahul Modi |
| Exit load | Exit load of 0.50%, if redeemed within 3 months. | Exit load of 1% if redeemed within 1 month. |
Invesco India Pharma and Healthcare vs Nippon India Power & Infra: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| Invesco India Pharma and Healthcare Fund (Direct) | +0.73% | -- | -- | -- | -- | -- | -- |
| Nippon India Power & Infra Fund (Direct) | −5.27% | −7.40% | −7.57% | −2.17% | +16.41% | +18.38% | +16.60% |
| Sectoral average | −1.70% | −4.49% | +2.30% | −0.58% | +15.61% | +14.51% | +14.77% |
Category average: the average of the 20 Sectoral funds, same plan type.
Invesco India Pharma and Healthcare vs Nippon India Power & Infra: Year-wise Returns
| Year | Invesco India Pharma and HealthcareInvesco India Pharma and Healthcare | Nippon India Power & InfraNippon India Power & Infra |
|---|---|---|
| 2026to date | -- | +1.60% |
| 2025 | -- | +0.37% |
| 2024 | -- | +27.98% |
| 2023 | -- | +59.03% |
| 2022 | -- | +11.64% |
| 2021 | -- | +49.69% |
Invesco India Pharma and Healthcare vs Nippon India Power & Infra: Rolling Returns
Every holding period of both funds, against BSE Healthcare TRI, the benchmark of Invesco India Pharma and Healthcare Fund
Invesco India Pharma and Healthcare vs Nippon India Power & Infra: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | Invesco India Pharma and Healthcare Fund (Direct) | Nippon India Power & Infra Fund (Direct) |
|---|---|---|
| Return (CAGR) | −23.45% | +14.28% |
| Standard deviation | 18.70% | 18.67% |
| Sharpe ratio | -1.54 | 0.44 |
| Sortino ratio | -2.20 | 0.59 |
| Maximum drawdown | −11.4% (23-10-2026) | −53.2% (24-03-2020) |
| Beta | 1.00 | 0.87 |
| Alpha | −8.00% | +4.30% |
From daily NAVs, 10-09-2026 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
Invesco India Pharma and Healthcare Fund (Direct)
Nippon India Power & Infra Fund (Direct)
BSE Healthcare TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| Invesco India Pharma and Healthcare Fund (Direct) | −11.4% | 23-09-2026 | 23-10-2026 | Not yet | -- | −4.4% |
| Nippon India Power & Infra Fund (Direct) | −10.4% | 23-09-2026 | 23-10-2026 | Not yet | -- | −8.3% |
| BSE Healthcare TRI | −9.9% | 23-09-2026 | 23-10-2026 | Not yet | -- | −3.8% |
From daily values since 10-09-2026, the first day every fund has.
Invesco India Pharma and Healthcare vs Nippon India Power & Infra: Portfolio Overlap
From each fund's latest monthly portfolio: Invesco India Pharma and Healthcare Fund, September 2026; Nippon India Power & Infra Fund, September 2026
Holdings in common
- Overlap
- 1.4%
- Held by both
- 2
- Only in Invesco India Pharma and Healthcare
- 11
- Only in Nippon India Power & Infra
- 82
| Security | % of Invesco India Pharma and Healthcare | % of Nippon India Power & Infra |
|---|---|---|
| Apollo Hospitals Enterprise Limited | 8.03% | 0.90% |
| Krishna Institute Of Medical Sciences Limited | 4.72% | 0.50% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 1.4% means 1.4% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in Invesco India Pharma and Healthcare Fund
| Security | % of fund |
|---|---|
| Max Healthcare Institute Limited | 9.58% |
| Sun Pharmaceutical Industries Limited | 8.99% |
| Sai Life Sciences Limited | 8.63% |
| Manipal Health Enterprises Ltd | 7.98% |
| Divi's Laboratories Limited | 7.85% |
Largest holdings only in Nippon India Power & Infra Fund
| Security | % of fund |
|---|---|
| Reliance Industries Limited | 7.03% |
| Larsen & Toubro Limited | 5.33% |
| NTPC Limited | 5.17% |
| NTPC Green Energy Limited | 4.29% |
| Bharat Heavy Electricals Limited | 3.38% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | Invesco India Pharma and Healthcare | Nippon India Power & Infra |
|---|---|---|
| Equity | 87.0% | 99.3% |
| Debt | 0.0% | 0.0% |
| Cash and others | 13.0% | 0.7% |
Market cap of stocks
| Market cap | Invesco India Pharma and Healthcare | Nippon India Power & Infra |
|---|---|---|
| Large Cap | 29.8% | 47.1% |
| Mid Cap | 16.4% | 23.1% |
| Small Cap | 32.8% | 25.0% |
| Not on AMFI's list | 8.0% | 4.0% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | Invesco India Pharma and Healthcare | Nippon India Power & Infra |
|---|---|---|
| Healthcare Services | 45.6% | 1.4% |
| Pharmaceuticals & Biotechnology | 41.4% | 0.0% |
| Power | 0.0% | 18.3% |
| Electrical Equipment | 0.0% | 15.2% |
| Auto Components | 0.0% | 7.6% |
| Petroleum Products | 0.0% | 7.0% |
| Construction | 0.0% | 7.0% |
| Industrial Products | 0.0% | 6.3% |
The six largest sectors of each fund's stocks, % of the fund.
Invesco India Pharma and Healthcare vs Nippon India Power & Infra: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | Invesco India Pharma and Healthcare Fund | Nippon India Power & Infra Fund |
|---|---|---|
| Total expense ratio (Direct) | 3.30% | 1.11% |
| Base expense ratio (Direct) | 0.50% | 0.81% |
| Total expense ratio (Regular) | 5.19% | 1.96% |
| Base expense ratio (Regular) | 2.10% | 1.54% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare Invesco India Pharma and Healthcare with
Invesco India Pharma and Healthcare Fund vs Nippon India Power & Infra Fund: Frequently Asked Questions
What is the difference between Invesco India Pharma and Healthcare Fund and Nippon India Power & Infra Fund?
Invesco India Pharma and Healthcare Fund is a Sectoral fund, Nippon India Power & Infra Fund is a Sectoral fund, run by Invesco Mutual Fund and Nippon India Mutual Fund. Their portfolios overlap 1.4%. Invesco India Pharma and Healthcare Fund charges 3.30% a year and Nippon India Power & Infra Fund 1.11%.
Which has the lower expense ratio, Invesco India Pharma and Healthcare Fund or Nippon India Power & Infra Fund?
Nippon India Power & Infra Fund charges less: 1.11% a year against 3.30%. These are the Direct plans' total expense ratios reported to AMFI.
How much do Invesco India Pharma and Healthcare Fund and Nippon India Power & Infra Fund overlap?
1.4%. They hold 2 of the same securities, the largest shared ones being APOLLOHOSP, KIMS. From each fund's latest monthly portfolio.
Which is riskier, Invesco India Pharma and Healthcare Fund or Nippon India Power & Infra Fund?
On SEBI's riskometer, Invesco India Pharma and Healthcare Fund is rated Very High and Nippon India Power & Infra Fund Very High. Over their common history, the standard deviation of daily returns was 18.70% and 18.67% a year.
Can I invest in both Invesco India Pharma and Healthcare Fund and Nippon India Power & Infra Fund?
Yes. 1.4% of each fund's money sits in the same holdings, so the two hold mostly different investments.
Who manages Invesco India Pharma and Healthcare Fund and Nippon India Power & Infra Fund?
Invesco India Pharma and Healthcare Fund: Aditya Khemani. Nippon India Power & Infra Fund: Rahul Modi.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.